Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 174 publications.

Amin RP, Hamadeh HK, Bushel PR, Bennett L, Afshari CA, Paules RS. Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology. 2002 Dec 27;181-182:555-63.

Fehnel SE, McLeod LD, Brandman J, Arbit DI, McLaughlin-Miley CJ, Coombs JH, Martin AR, Girman CJ. Responsiveness of the acne-specific quality of life questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res. 2002 Dec 1;11(8):809-16.

Honeycutt AA, Richter A, Earnshaw SR, Hicks KA. A model for allocating hiv prevention resources. Poster presented at the CDC's "Practical Use of CEA" 01158 Grantee Meeting; December 2002.

Whalley D, Huels J, McKenna SP, van Assche D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis. Pediatrics. 2002 Dec 1;110(6):1133-6.

Duff SB, Mordin MM. Strategies for assessing health economic and quality-of-life outcomes in multiple sclerosis. Expert Rev Pharmacoecon Outcomes Res. 2002 Dec;2(6):577-87.

Gomma AH, Elrayess MA, Knight C, Hawe E, Fox KM, Humphries SE. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J. 2002 Dec;23(24):1955-62.

Sacco P, Luo R, Chang S, Sung D, Gause D. Potential benefits of rivastigmine in the nursing home population with alzheimer's disease. Poster presented at the Gerontological Society of America; December 2002. Boston, MA.

Blair RM, Appt SE, Bennetau-Pelissero C, Clarkson TB, Anthony MS, Lamothe V, Potter SM. Dietary soy and soy isoflavones have gender-specific effects on plasma lipids and isoflavones in golden Syrian f(1)b hybrid hamsters. J Nutr. 2002 Dec;132(12):3585-91.

Castellsague J, García-Rodríguez LA, Duque A, Perez-Gutthann S. Risk of severe cutaneous disorders in users of oral antifungals. BMC Dermatology. 2002 Nov 28;2(14). doi: 10.1186/1471-5945-2-14

Anthony MS. Soy protein and coronary heart disease and CHD risk factors. Presented at the 2nd International Symposium on Soybean and Human Health; November 15, 2002. Seoul, South Korea.

McKenna SP, Whalley D, Doward LC. Improving the measurement properties of the quality of life in depression scale. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov 3; 5(6):522.

Doward LC, Ratcliffe J, McKenna SP, Meads DM, Langley PC. A comparison of conjoint analysis and time trade off elicited utilities for quality of life states associated with the treatment of genital herpes. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. [abstract] Value Health. 2002 Nov 3; 5(6):574. doi: 10.1016/S1098-3015(10)61510-0

Meads DM, Whalley D, Van t' Kooster GA. Review of QoL and HRQoL instruments available for measuring outcome in HIV/AIDS. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov 3; 5(6):572.

Fehnel SE, McLeod LD, Pendergast K, Hogue SL, Harrison DJ, Mahajan SS. Further psychometric evaluation of the motivation and energy inventory (MEI). Poster presented at the Annual International Society for Quality of Life Research (ISOQOL) Conference; November 2002.

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles. Cancer Causes Control. 2002 Nov;13(9):807-11.

Doward LC, McKenna SP, Meads DM, Ratcliffe J, Whalley D, Langley PC. Investigation into the feasibility of deriving relative and absolute utility from the recurrent genital herpes quality of life questionnaire (RGHQOL). Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov; 5(6):573-4.

McLeod LD, Fehnel SE, Williams VS. Psychometrics for the non-psychometrician. Presented at the Annual International Society for Quality of Life Research (ISOQOL) Conference; November 2002. Previously presented at the Seventh Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.

Brogan AJ, Stidham S. Portfolio optimization risk measures: variance versus target semivariance. Presented at the Annual Meeting of the Institute for Operations Research and Management Science; November 2002.

Soni MK, Cella D, Masters GA, Burch SP, Heyes AE, Silberman C. The validity and clinical utility of symptom monitoring in advanced lung cancer: a literature review. Clin Lung Cancer. 2002 Nov;4(3):153-60.

Clarkson TB, Anthony MS, Mikkola TS, St. Clair RW. Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys. Stroke. 2002 Nov;33(11):2700-3.

Adams MR, Golden DL, Register TC, Anthony MS, Hodgin JB, Maeda N, Williams JK. The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1859-64.

Watts (Wideman) KB, McAvinchey G, Ladner A. Demographic characteristics as indicators of performance on the Spanish language skills assessment. Poster presented at the 21st Annual Conference of the Southern Association for Public Opinion Research; October 2002. Raleigh, NC.

Yves L, Nuss P, Davis KH, Harris SL. Characteristics of a large cohort of patients with bipolar disorder. Poster presented at the American Psychiatric Association Institute of Psychiatric Services; October 2002.

Yves L, Nuss P, Davis KH, Harris SL. Demographic and clinical characteristics of individuals in a set of large bipolar disorder I maintenance studies. Poster presented at the European Congress of Neuropsychopharmacology;; October 2002. Barcelona, Spain.

Yves L, Nuss P, Davis KH, Harris SL. Quality of life in bipolar versus unipolar depression and US population norms. Poster presented at the American Psychiatric Association Institute of Psychiatric Services; October 2002.

Coombs J, McBurney C, Gondek K, Copley-Merriman C. Evidence of patient reported outcomes in labeling for oncology products: evaluation of United States and European labels. Mapi Quality of Life Newsletter. 2002 Oct;29:1-3.

Dykstra LA, Granger AL, Allen RM, Zhang X, Rice KC. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Psychopharmacology (Berl). 2002 Oct 1;163(3-4):420-9.

Davis KH, Chang L, Moore M, Horrigan J. Prevalence and economic burden of attentiondeficit/hyperactivity disorder. Poster presented at the Children and Adults with Attention-Deficit/Hyperactivity Disorder; October 2002. Previously presented at the American Academy of Child & Adolescent Psychiatry.

Davis KH, Chang L, Moore M, Horrigan J. Prevalence and economic burden of attentiondeficit/hyperactivity disorder. Poster presented at the American Academy of Child & Adolescent Psychiatry; October 2002.

Douillard JY, Skarin A, Baselga J, Natale R, Giaccone G, Maddox A, Heyes AE. Improvement in disease-related symptoms and quality of life (QOL) in patients treated with advanced non-small cell lung cancer (NSCLC) treated with zd1839 in ideal1 and ideal2. Poster presented at the European Society for Medical Oncology; October 2002. Nice, France.

Gilsenan AW. Depression and pain in the primary care setting. Presented at the Correlation Between Depression and Pain: Creating a New Treatment Paradigm to Evaluate Cost and Caliber of Care. Symposia at the Academy of Managed Care Pharmacy 2002 Educational Conference; October 2002. Washington, DC.

Degen K, Neighbors DM, Irish W, Lopez R. Inpatient chart abstraction study of atypical antipsychotic resources and costs. Poster presented at the American Psychiatric Association 54th Institute on Psychiatric Services; October 2002. Chicago, IL.

Crawford SL, Johannes CB, Stellato RK. Assessment of digit preference in self-reported year at menopause: choice of an appropriate reference distribution. Am J Epidemiol. 2002 Oct 1;156(7):676-83.

Salerno DF, Copley-Merriman C, Taylor TN, Shinogle J, Schulz RM. A review of functional status measures for workers with upper extremity disorders. Occup Environ Med. 2002 Oct;59(10):664-70.

Berman SM, Chang L, Suyenobu B, Derbyshire SW, Stains J, Fitzgerald L, Mandelkern M, Hamm L, Vogt B, Naliboff BD, Mayer EA. Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. Gastroenterology. 2002 Oct 1;123(4):969-77.

Davis KH, Black L, Sleath B. Validation of the Patient Perception of Migraine Questionnaire. Value Health. 2002 Sep 1;5(5):421-9.

Poulos C, Smith VK. Selection bias in estimates of the value of open space. Poster presented at the Heartland Environmental and Resource Economics Workshop, Department of Agricultural Economics; September 2002. Ames, IA. Previously presented at the Camp Resources, Center for Environmental and Resource Economic Research.

Black C, Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ. 2002 Aug 24;325(7361):419-21.

Rivero E, Varas-Lorenzo C, Rueda de Castro A, Blanch C, Maguire A. Long-term prediction of coronary heart disease risk in a renal transplant clinical trial. Poster presented at the 18th ICPE International Conference on Pharmacoepidemiology; August 21, 2002. Edinburgh, Scotland. [abstract] Pharmacoepidemiol Drug Saf. 2002 Aug 21; 11(Suppl 1):S152.

Lovas K, Geher P, Whalley D, McKenna S, Meads D, Kalo Z. Hungarian adaptation of a disease-specific quality-of-life questionnaire in patients with ankylosing spondylitis. Orv Hetil. 2002 Aug 11;43(32):1893-7.

Andrews EB, Mitchell AA, Seligman P, Cook SF, Gilsenan AW. Risk management: what are we driving, where are we going, and how will we know when we get there? Presented at the 18th International Conference on Pharmacoepidemiology; August 2002.

Irish WD, Neighbors DM, Grogg A, Lopez R, Girts T, Paul J. Performing epidemiological studies in schizophrenia: a propensity score model to predict selection of atypical antipsychotic. Poster presented at the 18th International Conference on Pharmacoepidemiology; August 2002. Edinburgh, Scotland.

Poulos C, Smith VK. Selection bias in estimates of the value of open space. Poster presented at the Camp Resources, Center for Environmental and Resource Economic Research; August 2002. Wilmington, NC.

Doward LC, McKenna SP, Whalley D, Tennant A, Emery P, Griffiths B. Validating the Systemic Lupus Erythematosus Quality of Life (SLEQoL) instrument. Poster presented at the 9th Annual Conference of the International Society for Quality of Life Research (ISOQOL); October 2002. Orlando, FL. [abstract] Qual Life Res. 2002 Aug; 11(7):651.

Arana A, Cid Ruzafa J, Rueda de Castro AM, Warner BA, O'Sullivan D. Evaluation of the clozaril® patient monitoring service (CPMS) in the prevention of clozaril/leponex-induced white-blood-celltoxicity. Presented at the 18th International Conference on Pharmacoepidemiology; August 2002.

McLeod LD, Fehnel SE. Irt evaluation of quality of life questionnaires. Presented at the American Statistical Association Annual Meeting; August 2002.

Black C, Kaye JA, Jick H. Measles, mumps and rubella vaccine and risk of idiopathic thrombocytopaenic purpura. Poster presented at the 18th International Conference on Pharmacoepidemiology; August 17, 2002. Edinburgh, Scotland. [abstract] Pharmacoepidemiol Drug Saf. 2002 Aug; 11(S8).

Saddier P, Saah A, Turpin J, Su L, Cai B, DeMuro-Mercon CJ. Historical controls for noncomparative clinical trials: methodological challenges. Poster presented at the International Society for Pharmacoepidemiology; August 2002.

Njue AI, Prichard RK. Is tubulin linked to ivermectin resistance? Poster presented at the 10th International Congress of Parasitology; August 2002.

Mendez MA, Anthony MS, Arab L. Soy-based formulae and infant growth and development: a review. J Nutr. 2002 Aug;132(8):2127-30.